key: cord-0974535-y0no215g authors: Roncati, Luca; Gianotti, Greta; Gravina, Davide; Attolini, Giovanna; Zanelli, Giuliana; Rosa, Norman Della; Adani, Roberto title: Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: a causal link? date: 2021-06-24 journal: Med Hypotheses DOI: 10.1016/j.mehy.2021.110638 sha: d4da3e45638ecf20c2273626ab488464e9769477 doc_id: 974535 cord_uid: y0no215g COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of variable entity in genetically predisposed subjects associated with myxoid nerve degeneration. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the single-stranded RNA virus causing Coronavirus Disease 2019 , is able to infect the human cells via Angiotensin-Converting Enzyme 2 (ACE2) receptors, present in many tissues including the synovial one [1, 2] . Synovium is a specialized connective tissue, which lines the synovial bursae, the inner surface of synovial joint capsules and the tendon sheaths. More in particular, the synovial membrane is found where the tendon runs under ligaments and through osteofibrous tunnels, such as carpal, cubital or tarsal tunnels; its function is to reduce friction between the tendon and the surrounding structures. During viral infections, synovium may be the direct target of the pathogen attack, as in the case of Ross River virus, the single-stranded RNA virus responsible for the so called "epidemic polyarthritis", or it can be indirectly involved through immunocomplexes deposition [3, 4] . In COVID-19, this deposition can also occur in vascular walls causing leukocytoclastic vasculitis [5] ; moreover, COVID-19-related abnormal immunothrombosis and SARS-CoV-2-induced demyelination have been described [6] [7] [8] [9] . Reactive arthritis after COVID-19 has been reported by different authors during the ongoing pandemic [10] [11] [12] ; all the synovial fluid cultures and polymerase chain reactions proved negative, suggesting that it can be the result of a type III hypersensitivity reaction or of an autoimmune response involving cross-reactivity between SARS-CoV-2 antigens and synoviocytes, quite similar to what happens in seronegative rheumatoid arthritis, the well-known autoimmune disorder primarily affecting the synovial membrane [13] . Since carpal, cubital or tarsal tunnel syndrome is sometimes an accompanying event of rheumatoid arthritis [13] [14] [15] , it is likely that a reactive arthritis after COVID-19 with irritation and thickening of the synovial sheaths may lead to a compression of the median, ulnar or tibial nerve inside the respective tunnels, such as to require decompressive surgery. Besides, we also hypothesize that the same pain can be exacerbated, even in absence of synovitis or significant compression, if the nerve is subjected to SARS-CoV-2-induced demyelination or ischemic insult due to peripheral microangiopathy triggered by a COVID-19-related hypercoagulative state. In both these conditions, there is no relevant inflammatory infiltrate, but the nerve anyway undergoes myxoid degeneration, also known as "mucoid" or "mucinous" degeneration, real expression of a nerve injury (Fig. 1) . In support of this hypothesis, we provide our two-cases experience of concomitant carpal and cubital syndrome after SARS-CoV-2 infection in the non-dominant limb of as many middle-aged male patients. A 47-year-old left-handed man with past medical history of sporadic hyperglycemic peaks suffered from COVID-19, as ascertained by molecular nasopharyngeal swab. The disease began with hyperpyrexia (40°C), dyspnea plus diarrhea, and progressed towards a clinical picture of septic pneumonia. The patient entered hospital in serious respiratory condition, slipped into a coma and woke up 35 days later, intubated with tracheotomy results. He tested positive at molecular swab for all 35 days, after which he was discharged. In the post-COVID-19 period, he developed a LADA (latent autoimmune diabetes in adults) diabetes mellitus and a right carpal and cubital syndrome, as confirmed by electromyography. On January 26, 2021, he was submitted to decompressive surgery; today, he is alive and well. A 51-year-old right-handed man with low level of vitamin D in anamnesis contracted COVID-19, as proved by molecular nasopharyngeal swab. He remained positive at the test for 33 consecutive days. The disease began with fever and dry cough; following the onset of dyspnea, the patient was hospitalized and stayed in hospital for 22 days, 10 of which intubated. After discharge, during the post-COVID-19 period, he developed a left carpal and cubital syndrome, as highlighted by electromyography. On March 30, 2021, he was submitted to decompressive surgery; today, he is alive and well, with only slight paresthesia at the fifth finger. Tunnel syndromes and related neuropathies appear to be possible sequelae of severe COVID-19, responding favorably to decompressive surgery. More cases are needed in order to convert our working hypothesis into a certain fact, to confirm a middle-aged male predominance, and to understand the real pathogenetic mechanism underlying this association. None. No conflict of interest. On microscopy, small nerve collaterals are in myxoid degeneration (C, hematoxylin & eosin, 20x objective), well highlighted by histochemistry, which stains mucins in light blue (D, Alcian Blue, 20x objective). Immunohistochemistry for S100 protein labels in brown the nerve collaterals through diaminobenzidine as chromogen (E, clone 4C4.9, Ventana Medical Systems, 20x objective), while immunohistochemistry for SARS-CoV-2 nucleoprotein does not reveal any positivity in the excised tissue, to suggest an indirect effect of viral infection (F, clone FIPV3-70, Santa Cruz Biotechnology, 20x objective). Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2 Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin 6 through STAT3 signaling in synovial tissues Ross River virus transmission, infection, and disease: a crossdisciplinary review What about the original antigenic sin of the humans versus SARS-CoV-2? Type 3 hypersensitivity in COVID-19 vasculitis A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients The COVID-19 arterial thromboembolic complications: from inflammation to immunothrombosis through antiphospholipid autoantibodies Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation The first reactive arthritis case associated with COVID-19 Reactive arthritis after COVID-19 Post-COVID-19 arthritis: a case report and literature review Carpal tunnel syndrome in rheumatoid arthritis Cubital tunnel syndrome in rheumatoid arthritis This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.